SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-20-139861
Filing Date
2020-12-28
Accepted
2020-12-28 17:06:35
Documents
2
Group Members
DAK CAPITAL INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2039451d1_sc13d.htm SC 13D 78086
2 EXHIBIT 99.1 tm2039451d1_ex99-1.htm EX-99.1 4617
  Complete submission text file 0001104659-20-139861.txt   84088
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Subject) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86661 | Film No.: 201419052
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1702 BELL TOWER, 10104-103 AVENUE EDMONTON Z4 T5J 0H8
Business Address
KATZ DARYL (Filed by) CIK: 0001625637 (see all company filings)

Type: SC 13D